Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Johnson and Johnson
Chubb
Chinese Patent Office
QuintilesIMS
Citi

Generated: April 21, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018859

« Back to Dashboard

NDA 018859 describes VIRAZOLE, which is a drug marketed by Valeant Pharm Intl and is included in one NDA. It is available from two suppliers. Additional details are available on the VIRAZOLE profile page.

The generic ingredient in VIRAZOLE is ribavirin. There are fifteen drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the ribavirin profile page.
Summary for 018859
Tradename:VIRAZOLE
Applicant:Valeant Pharm Intl
Ingredient:ribavirin
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 018859
Medical Subject Heading (MeSH) Categories for 018859
Suppliers and Packaging for NDA: 018859
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
VIRAZOLE ribavirin FOR SOLUTION;INHALATION 018859 NDA Valeant Pharmaceuticals North America LLC 0187-0007 0187-0007-14 4 VIAL, GLASS in 1 CARTON (0187-0007-14) > 1 POWDER, FOR SOLUTION in 1 VIAL, GLASS
VIRAZOLE ribavirin FOR SOLUTION;INHALATION 018859 NDA Oceanside Pharmaceuticals 68682-019 68682-019-06 4 VIAL, GLASS in 1 CARTON (68682-019-06) > 1 POWDER, FOR SOLUTION in 1 VIAL, GLASS

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:FOR SOLUTION;INHALATIONStrength6GM/VIAL
Approval Date:Dec 31, 1985TE:ANRLD:Yes

Expired US Patents for NDA 018859

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Valeant Pharm Intl VIRAZOLE ribavirin FOR SOLUTION;INHALATION 018859-001 Dec 31, 1985 ➤ Try a Free Trial ➤ Try a Free Trial
Valeant Pharm Intl VIRAZOLE ribavirin FOR SOLUTION;INHALATION 018859-001 Dec 31, 1985 ➤ Try a Free Trial ➤ Try a Free Trial
Valeant Pharm Intl VIRAZOLE ribavirin FOR SOLUTION;INHALATION 018859-001 Dec 31, 1985 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

Subscribe to access the full database, or try a Free Trial

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Deloitte
Chubb
Harvard Business School
Teva
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.